PFIZER-NOVO NORDISK PATENT HEARING SET FOR DECEMBER

Novo Nordisk A/S won't be able to get a preliminary injunction to block sales of Pfizer Inc.'s Exubera inhalable insulin before Pfizer's planned launch of the product in September.
Market Watch